Autolus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AUTL and other ETFs, options, and stocks.

About AUTL

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. 

CEO
Christian Martin Itin
CEOChristian Martin Itin
Employees
647
Employees647
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2018
Founded2018
Employees
647
Employees647

AUTL Key Statistics

Market cap
340.66M
Market cap340.66M
Price-Earnings ratio
-1.44
Price-Earnings ratio-1.44
Dividend yield
—
Dividend yield—
Average volume
2.74M
Average volume2.74M
High today
$1.30
High today$1.30
Low today
$1.19
Low today$1.19
Open price
$1.21
Open price$1.21
Volume
1.59M
Volume1.59M
52 Week high
$5.00
52 Week high$5.00
52 Week low
$1.11
52 Week low$1.11

Analyst ratings

100%

of 11 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.